Dr. Gary Aghazarian, DO

Dr. Aghazarian practices at Penn State Health Hampden Medical Center in Enola, Pennsylvania, part of Penn State.

Dr. Aghazarian's NPI, 1235513383, was assigned on July 17, 2015. Dr. Aghazarian graduated from Philadelphia College of Osteopathic Medicine in 2015. Dr. Aghazarian holds Pennsylvania license OS018580.

Dr. Aghazarian's primary practice is Penn State Health Hampden Medical Center, at 2200 Good Hope Road, Enola, PA 17025 in Cumberland County. The practice phone is (717) 981-9000.

Dr. Aghazarian's primary practice is Penn State Health Hampden Medical Center in Enola, Pennsylvania, part of Penn State. Dr. Aghazarian is also affiliated with Penn State Health Milton S. Hershey Medical Center. The medical group on file is Penn State Health Medical Group. Dmand AI also links Dr. Aghazarian to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aghazarian practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Aghazarian's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Aghazarian's licenses on file in 2 states: Pennsylvania and Florida.

CMS data shows 193 Medicare services from Dr. Aghazarian across 8 procedure codes in 2024, for 138 Medicare patients. Medicare paid $14,825 for them.

CMS counts 138 Medicare patients who saw Dr. Aghazarian in 2026. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aghazarian's median patient age at 62, with 52% women.

In 2026, Dr. Aghazarian wrote 50 Medicare Part D claims for 27 patients. 94% of them were for generic drugs. They cover 2 drugs, with $171 in total drug cost. In 2018, CMS named 47 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Aghazarian for performance year 2026, reported as part of a group. Dr. Aghazarian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Aghazarian, published from 2014 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Bariatric Surgery, Length of Stay and Analgesics, Opioid. Dr. Aghazarian has published most often in Surg Laparosc Endosc Percutan Tech. Dr. Aghazarian's most frequent co-authors are Andre F. Teixeira, MD, Muhammad Ghanem, MD and David Alexander Motola, MD.

CMS Open Payments shows 61 general payments to Dr. Aghazarian from 10 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 42% of the total. Intuitive Surgical, Inc. paid the most, $6,332.

Dr. Aghazarian graduated from Philadelphia College of Osteopathic Medicine in 2015.